chevron_leftBack
K
As of 24 April 2025, Kestra Medical Technologies, Ltd. has a market cap of $1.25B USD, ranking #7184 globally and #1703 in the United States. It ranks #684 in the Healthcare sector, and #64 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$1.25BUSD
Enterprise Value
$1.24BUSD
Revenue (TTM)
$52.64MUSD
EBITDA (TTM)
-$68.88MUSD
Net Income (TTM)
-$95.07MUSD
EBITDA Margin
-131%
Profit Margin
-160%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Brian Webster
open_in_new
Employees
300
Founded
2014
IPO
06 Mar 2025
Website
kestramedical.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.4% | -1% | -2.4% | 6.1% | 6.1% | 6.1% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
KMTS
Kestra Medical Technologies Ltd
ISIN: BMG524411052
Shares Out.:
Shares Outstanding:
51.349M1
Shares Float:
20.143M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
24.34 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. This platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). It also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
